Clinical impacts of severe thrombocytopenia in the first cycle of azacitidine monotherapy and cytogenetics in patients with myelodysplastic syndrome: The Kyoto Conditional Survival Scoring System.
Saved in:
| Title: | Clinical impacts of severe thrombocytopenia in the first cycle of azacitidine monotherapy and cytogenetics in patients with myelodysplastic syndrome: The Kyoto Conditional Survival Scoring System. |
|---|---|
| Authors: | Inoue, Yu1 (AUTHOR), Okamoto, Haruya1 (AUTHOR), Miyashita, Akihiro1 (AUTHOR), Kawaji-Kanayama, Yuka1 (AUTHOR), Chinen, Shotaro1 (AUTHOR), Fujino, Takahiro1 (AUTHOR), Tsukamoto, Taku1 (AUTHOR), Shimura, Yuji1 (AUTHOR), Mizutani, Shinsuke1 (AUTHOR), Kaneko, Hiroto2 (AUTHOR), Kuwahara-Ota, Saeko3 (AUTHOR), Fuchida, Shin-Ichi3 (AUTHOR), Nishiyama, Daichi4 (AUTHOR), Hirakawa, Koichi4 (AUTHOR), Uchiyama, Hitoji5 (AUTHOR), Uoshima, Nobuhiko6 (AUTHOR), Kawata, Eri7 (AUTHOR), Kuroda, Junya1 (AUTHOR) junkuro@koto.kpu-m.ac.jp |
| Source: | Oncology Letters. Feb2024, Vol. 27 Issue 2, pN.PAG-N.PAG. 1p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
